NCT04682626View on ClinicalTrials.gov

Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 25, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

March 20, 2021

Conditions
Diabetes Mellitus, Type 2Kidney Diseases
Interventions
DIETARY_SUPPLEMENT

Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.

Soft gelatin capsules each contain 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.

Trial Locations (1)

Unknown

Mahmoud S Abu-Samak, Amman

All Listed Sponsors
lead

Applied Science Private University

OTHER

NCT04682626 - Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels | Biotech Hunter | Biotech Hunter